Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Senti Bio Doses First Patient In Phase 1 Trial Of SENTI-202 In Relapsed Or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia

Author: Benzinga Newsdesk | May 13, 2024 08:17am

Posted In: SNTI